Determination of schizandrin in human plasma by gas chromatography-mass spectrometry. 1995

H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
Tsumura Central Research Laboratories, Ibaraki, Japan.

Schizandrin (SZ) is one of the lignan components from Schisandra fruits. A highly sensitive and precise method for the determination of SZ in human plasma was developed involving selected-ion monitoring with gas chromatography-mass spectrometry using a fused-silica capillary column. A 0.1-ml plasma sample was used for solid-phase extraction. A good linear relationship was obtained in the concentration range studied (2.0-500 ng/ml) and the method was sufficiently accurate and precise to support clinical pharmacokinetic studies. After oral administration of SZ at a dose of 15 mg to healthy male subjects, the average value of the maximum plasma concentration of SZ was 96.1 +/- 14.1 ng/ml. The plasma concentration of this substance could be monitored for 8 h after administration.

UI MeSH Term Description Entries
D008297 Male Males
D008401 Gas Chromatography-Mass Spectrometry A microanalytical technique combining mass spectrometry and gas chromatography for the qualitative as well as quantitative determinations of compounds. Chromatography, Gas-Liquid-Mass Spectrometry,Chromatography, Gas-Mass Spectrometry,GCMS,Spectrometry, Mass-Gas Chromatography,Spectrum Analysis, Mass-Gas Chromatography,Gas-Liquid Chromatography-Mass Spectrometry,Mass Spectrometry-Gas Chromatography,Chromatography, Gas Liquid Mass Spectrometry,Chromatography, Gas Mass Spectrometry,Chromatography, Mass Spectrometry-Gas,Chromatography-Mass Spectrometry, Gas,Chromatography-Mass Spectrometry, Gas-Liquid,Gas Chromatography Mass Spectrometry,Gas Liquid Chromatography Mass Spectrometry,Mass Spectrometry Gas Chromatography,Spectrometries, Mass-Gas Chromatography,Spectrometry, Gas Chromatography-Mass,Spectrometry, Gas-Liquid Chromatography-Mass,Spectrometry, Mass Gas Chromatography,Spectrometry-Gas Chromatography, Mass,Spectrum Analysis, Mass Gas Chromatography
D010946 Plants, Medicinal Plants whose roots, leaves, seeds, bark, or other constituent parts possess therapeutic, tonic, purgative, curative or other pharmacologic attributes, when administered to man or animals. Herbs, Medicinal,Medicinal Herbs,Healing Plants,Medicinal Plants,Pharmaceutical Plants,Healing Plant,Herb, Medicinal,Medicinal Herb,Medicinal Plant,Pharmaceutical Plant,Plant, Healing,Plant, Medicinal,Plant, Pharmaceutical,Plants, Healing,Plants, Pharmaceutical
D011083 Polycyclic Compounds Compounds which contain two or more rings in their structure. Compounds, Polycyclic
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D017705 Lignans A class of dibenzylbutane derivatives which occurs in higher plants and in fluids (bile, serum, urine, etc.) in man and other animals. These compounds, which have a potential anti-cancer role, can be synthesized in vitro by human fecal flora. (From Singleton & Sainsbury, Dictionary of Microbiology and Molecular Biology, 2d ed) Lignan,Neolignan,Neolignans
D034242 Cyclooctanes A group of compounds with an 8-carbon ring. They may be saturated or unsaturated. Benzocyclooctanes,Benzocyclooctenes,Cyclooctenes,Cyclooctodienes,Dibenzocyclooctanes

Related Publications

H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
July 1993, Journal of chromatography,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
December 1992, Journal of chromatography,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
January 1995, Biomedical chromatography : BMC,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
July 2002, The Analyst,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
September 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
February 1985, Journal of chromatography,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
November 1989, Biomedical & environmental mass spectrometry,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
October 1983, Biomedical mass spectrometry,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
January 1991, Journal of chromatography,
H Ono, and Y Matsuzaki, and Y Wakui, and S Takeda, and Y Ikeya, and S Amagaya, and M Maruno
September 1982, Journal of chromatography,
Copied contents to your clipboard!